These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17145945)

  • 1. Streptococcus pneumoniae pilus subunits protect mice against lethal challenge.
    Gianfaldoni C; Censini S; Hilleringmann M; Moschioni M; Facciotti C; Pansegrau W; Masignani V; Covacci A; Rappuoli R; Barocchi MA; Ruggiero P
    Infect Immun; 2007 Feb; 75(2):1059-62. PubMed ID: 17145945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis.
    Villena J; Medina M; Racedo S; Alvarez S
    J Microbiol Immunol Infect; 2010 Feb; 43(1):1-10. PubMed ID: 20434117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined protective effects of anti-PhtD and anti-pneumococcal polysaccharides.
    Denoël P; Godfroid F; Hermand P; Verlant V; Poolman J
    Vaccine; 2011 Sep; 29(38):6451-3. PubMed ID: 21315695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with the RrgB321 fusion protein protects mice against both high and low pilus-expressing Streptococcus pneumoniae populations.
    Moschioni M; De Angelis G; Harfouche C; Bizzarri E; Filippini S; Mori E; Mancuso G; Doro F; Barocchi MA; Ruggiero P; Masignani V
    Vaccine; 2012 Feb; 30(7):1349-56. PubMed ID: 22210141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal Immunization with the Commensal
    Shekhar S; Khan R; Schenck K; Petersen FC
    Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection.
    Brown JS; Ogunniyi AD; Woodrow MC; Holden DW; Paton JC
    Infect Immun; 2001 Nov; 69(11):6702-6. PubMed ID: 11598041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the antibody response elicited by immunization with pneumococcal surface protein A (PspA) as recombinant protein or DNA vaccine and analysis of protection against an intranasal lethal challenge with Streptococcus pneumoniae.
    Vadesilho CF; Ferreira DM; Moreno AT; Chavez-Olortegui C; Machado de Avila RA; Oliveira ML; Ho PL; Miyaji EN
    Microb Pathog; 2012; 53(5-6):243-9. PubMed ID: 22981893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal and systemic immunization with a novel attenuated pneumococcal vaccine candidate confer serotype independent protection against Streptococcus pneumoniae in mice.
    Wu K; Yao R; Wang H; Pang D; Liu Y; Xu H; Zhang S; Zhang X; Yin Y
    Vaccine; 2014 Jul; 32(33):4179-88. PubMed ID: 24945468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.
    Saeland E; Jakobsen H; Ingolfsdottir G; Sigurdardottir ST; Jonsdottir I
    J Infect Dis; 2001 Jan; 183(2):253-260. PubMed ID: 11110649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with DnaJ (hsp40) could elicit protection against nasopharyngeal colonization and invasive infection caused by different strains of Streptococcus pneumoniae.
    Cui Y; Zhang X; Gong Y; Niu S; Yin N; Yao R; Xu W; Li D; Wang H; He Y; Cao J; Yin Y
    Vaccine; 2011 Feb; 29(9):1736-44. PubMed ID: 21238570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
    Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
    Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against fatal pneumonia through mucosal and subcutaneous immunization with the pneumococcal SP0148 protein.
    Huang J; Luo S; Huang M; Zhang T; Min Z; Liu C; Zhang Q; Yang J; Min X
    Microb Pathog; 2019 Apr; 129():206-212. PubMed ID: 30772476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodies.
    Brookes RH; Ming M; Williams K; Hopfer R; Gurunathan S; Gallichan S; Tang M; Ochs MM
    Hum Vaccin Immunother; 2015; 11(7):1836-9. PubMed ID: 25912273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against pneumococcal infection elicited by immunization with multiple pneumococcal heat shock proteins.
    Cao J; Zhang X; Gong Y; Zhang Y; Cui Y; Lai X; Yin Y; Li M; Li D; Zhang L
    Vaccine; 2013 Aug; 31(35):3564-71. PubMed ID: 23727004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of Streptococcus pneumoniae serotype 6B infection in mice after passive immunization with human serum.
    Aaberge IS; Hvalbye B; Løvik M
    Microb Pathog; 1996 Aug; 21(2):125-37. PubMed ID: 8844655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against pneumococcal infection elicited by immunization with glutamyl tRNA synthetase, polyamine transport protein D and sortase A.
    Min X; Zhang X; Wang H; Gong Y; Li M; Xu W; Yin Y; Cao J
    Vaccine; 2012 May; 30(24):3624-33. PubMed ID: 22464966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
    Cao J; Chen D; Xu W; Chen T; Xu S; Luo J; Zhao Q; Liu B; Wang D; Zhang X; Shan Y; Yin Y
    Vaccine; 2007 Jun; 25(27):4996-5005. PubMed ID: 17524530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized and can protect splenectomized mice from infection with Streptococcus pneumoniae.
    Coats MT; Benjamin WH; Hollingshead SK; Briles DE
    Vaccine; 2005 Jul; 23(33):4257-62. PubMed ID: 16005736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RrgB321, a fusion protein of the three variants of the pneumococcal pilus backbone RrgB, is protective in vivo and elicits opsonic antibodies.
    Harfouche C; Filippini S; Gianfaldoni C; Ruggiero P; Moschioni M; Maccari S; Pancotto L; Arcidiacono L; Galletti B; Censini S; Mori E; Giuliani M; Facciotti C; Cartocci E; Savino S; Doro F; Pallaoro M; Nocadello S; Mancuso G; Haston M; Goldblatt D; Barocchi MA; Pizza M; Rappuoli R; Masignani V
    Infect Immun; 2012 Jan; 80(1):451-60. PubMed ID: 22083702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.